NCT05059600View on ClinicalTrials.gov

A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

July 14, 2022

Study Completion Date

July 14, 2022

Conditions
Postpartum Depression
Interventions
DRUG

ZULRESSO®

Intravenous infusion of ZULRESSO®.

Trial Locations (6)

10036

Sage Investigational Site, New York

33029

Sage Investigational Site, Miramar

33060

Sage Investigational Site, Pompano Beach

77573

Sage Investigational Site, League City

90230

Sage Investigational Site, Culver City

Virtual Site (recruiting nationwide), Culver City

All Listed Sponsors
lead

Supernus Pharmaceuticals, Inc.

INDUSTRY

NCT05059600 - A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting | Biotech Hunter | Biotech Hunter